Literature DB >> 20673746

Switch to high-level virus replication and HLA class I upregulation in differentiating megakaryocytic cells after infection with pathogenic hantavirus.

Nina Lütteke1, Martin J Raftery, Pritesh Lalwani, Min-Hi Lee, Thomas Giese, Sebastian Voigt, Norbert Bannert, Harald Schulze, Detlev H Krüger, Günther Schönrich.   

Abstract

Hantaan virus (HTNV), the prototype member of the Hantavirus genus in the family Bunyaviridae, causes hemorrhagic fever with renal syndrome (HFRS) in humans. Hemorrhage is due to endothelial barrier damage and a sharp decrease in platelet counts. The mechanisms underlying HTNV-associated acute thrombocytopenia have not been elucidated so far. Platelets are produced by mature megakaryocytes that develop during megakaryopoiesis. In this study, we show that HTNV targets megakaryocytic cells whereas rather non-pathogenic hantaviruses did not infect this cell type. After induction of differentiation megakaryocytic cells switched from low-level to high-level HTNV production without reduction in cell survival or alteration in differentiation. However, increased HTNV replication resulted in strong upregulation of HLA class I molecules although HTNV escaped type I interferon (IFN)-associated innate responses. Taken together, HTNV efficiently replicates in differentiating megakaryocytic cells resulting in upregulation of HLA class I molecules, the target structures for cytotoxic T cells (CTLs). Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20673746     DOI: 10.1016/j.virol.2010.05.028

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

Review 1.  HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition.

Authors:  Michael Campoli; Soldano Ferrone
Journal:  Semin Immunopathol       Date:  2011-04-28       Impact factor: 9.623

Review 2.  Hantaviruses as zoonotic pathogens in Germany.

Authors:  Detlev H Krüger; Rainer G Ulrich; Jörg Hofmann
Journal:  Dtsch Arztebl Int       Date:  2013-07-08       Impact factor: 5.594

3.  Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness.

Authors:  Erik Sundberg; Johan Hultdin; Sofie Nilsson; Clas Ahlm
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

Review 4.  Platelets in Viral Infections - Brave Soldiers or Trojan Horses.

Authors:  Waltraud C Schrottmaier; Anna Schmuckenschlager; Anita Pirabe; Alice Assinger
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

Review 5.  The role of platelets in the pathogenesis of viral hemorrhagic fevers.

Authors:  Juan C Zapata; Dermot Cox; Maria S Salvato
Journal:  PLoS Negl Trop Dis       Date:  2014-06-12

Review 6.  Platelets and infection - an emerging role of platelets in viral infection.

Authors:  Alice Assinger
Journal:  Front Immunol       Date:  2014-12-18       Impact factor: 7.561

7.  Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release.

Authors:  Marco Goeijenbier; Joost C M Meijers; Fatih Anfasa; Jeroen M Roose; Cornelia A M van de Weg; Kamran Bakhtiari; Heikki Henttonen; Antti Vaheri; Albert D M E Osterhaus; Eric C M van Gorp; Byron E E Martina
Journal:  Front Microbiol       Date:  2015-03-24       Impact factor: 5.640

Review 8.  What Do We Know about How Hantaviruses Interact with Their Different Hosts?

Authors:  Myriam Ermonval; Florence Baychelier; Noël Tordo
Journal:  Viruses       Date:  2016-08-11       Impact factor: 5.048

Review 9.  Platelets in Immune Response to Virus and Immunopathology of Viral Infections.

Authors:  Eugenio D Hottz; Fernando A Bozza; Patrícia T Bozza
Journal:  Front Med (Lausanne)       Date:  2018-04-30

Review 10.  Exploring the Immunopathogenesis of Viral Hemorrhagic Fever in Mice with a Humanized Immune System.

Authors:  Günther Schönrich; Martin J Raftery
Journal:  Front Immunol       Date:  2017-09-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.